SUSAN BLANEY to Carcinoma, Small Cell
This is a "connection" page, showing publications SUSAN BLANEY has written about Carcinoma, Small Cell.
Connection Strength
0.018
-
A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2008 Feb; 50(2):254-8.
Score: 0.018